Prevention Trials in Alzheimer’s Disease: Current Status and Future Perspectives-Reference-Cited by-同舟云学术

Prevention Trials in Alzheimer’s Disease: Current Status and Future Perspectives

Published:2016-02-22 Issue:4 Volume:50 Page:927-945
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Wang Jun¹²,Tan Lan¹,Yu Jin-tai³

Affiliation:

1. Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China

2. Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Yuzhong District, Chongqing, China

3. Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference127 articles.

1. 2010 Alzheimer’s disease facts and figures;Alzheimer’s Association;Alzheimers Dement,2010

2. Alzheimer’s disease: Clinical trials and drug development;Mangialasche;Lancet Neurol,2010

3. Disease-modifying therapies in Alzheimer’s disease;Salloway;Alzheimers Dement,2008

4. Anti-a(therapeutics in Alzheimer’s disease: The need for a paradigm shift;Golde;Neuron,2011

5. A phase 3 trial of agacestat for treatment of Alzheimer’s disease;Doody;N Engl J Med,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling new thiazole‐clubbed piperazine derivatives as multitarget anti‐AD: Design, synthesis, and in silico studies;Archiv der Pharmazie;2024-05-16

2. Herbal Components for the Treatment of Alzheimer's Disease;The Natural Products Journal;2023-11

3. Potential Therapeutics from Ayurveda, Siddha, and Homeopathic Medical System for Alzheimer’s Disease;Nutritional Neurosciences;2023

4. Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects;Journal of Alzheimer's Disease;2022-11-02

5. Role of Medicinal Plants against Neurodegenerative Diseases;Current Pharmaceutical Biotechnology;2022-01